Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
OwnerMarco Valgimigliinventor
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for reducing the risk of thrombocytopenia-associated mortality and morbidity, and for reducing the risk of becoming thrombocytopenic, in patients whose treatment requires inhibition of platelet aggregation. The methods involve administration of a pharmaceutically acceptable salt of tirofiban.
Claims9
A method for reducing the risk of thrombocytopenia-associated mortality which comprises administering to a patient suffering from a condition whose treatment requires the inhibition of platelet aggregation a therapeutically effective amount of a pharmaceutically acceptable salt of tirofiban.
A method for reducing the risk of becoming thrombocytopenic which comprises administering to a patient suffering from a condition whose treatment requires the inhibition of platelet aggregation a therapeutically effective amount of a pharmaceutically acceptable salt of tirofiban.
A method for reducing the risk of thrombocytopenia-associated morbidity which comprises administering to a patient suffering from a condition whose treatment requires the inhibition of platelet aggregation a therapeutically effective amount of a pharmaceutically acceptable salt of tirofiban.
Dependencies are inferred from the claim text.